— Know what they know.
Not Investment Advice
Also trades as: 0867.HK (HKSE) · $vol 9M · 2M7C.F (FSX) · $vol 0M

CHSYF OTC

China Medical System Holdings Limited
1W: +0.0% 1M: +13.8% 3M: +0.0% YTD: +16.3% 1Y: +16.3% 3Y: +10.6% 5Y: -16.0%
$1.57
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 58 · $3.8B mcap · 1.18B float · 0.0000% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.3B -49.3% ▼
5Y CAGR: -13.1%
Capital Expenditures
$456M -43.4% ▼
5Y CAGR: +6.0%
Free Cash Flow
$813M -62.8% ▼
5Y CAGR: -18.2%
Dividends Paid
$556M +59.1% ▲
Buybacks
$238M +0.0% ▲
Net Change in Cash
-$605M -825.6% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$2.8B$3.5B$3.8B$2.9B$2.0B
Depreciation & Amort.$208M$220M$227M$230M$259M
Stock-Based Comp.$0$17M$19M-$36M$0
Change in Working Capital$88M-$596M$90M$3M-$128M
Other Non-Cash Items-$421M-$56M-$56M-$568M-$873M
Operating Cash Flow$2.7B$2.5B$3.6B$2.5B$1.3B
— Investing Activities —
Capital Expenditures-$341M-$185M-$525M-$27M-$33M
Acquisitions (Net)$0-$564M-$299M-$124M-$67M
Investment Purchases-$157M-$869M-$459M-$378M-$343M
Investment Sales$0-$61M$3M$20M$6M
Other Investing$145M$159M$102M$67M-$179M
Investing Cash Flow-$354M-$1.5B-$1.2B-$442M-$615M
— Financing Activities —
Net Debt Issuance-$76M$1.1B-$70M-$528M-$443M
Stock Repurchased-$87M-$152M-$48M$0-$238M
Dividends Paid-$834M-$1.2B-$1.3B-$1.4B-$556M
Other Financing-$37M-$29M-$5M-$236M-$24M
Financing Cash Flow-$1.0B-$258M-$1.4B-$2.1B-$1.3B
Net Change in Cash$1.3B$717M$991M-$65M-$605M
Cash End of Period$2.7B$3.4B$4.4B$4.3B$3.7B
Free Cash Flow$2.4B$2.3B$3.0B$2.2B$813M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms